AbbVie
ABBV
#25
Rank
โ‚น48.365 T
Marketcap
โ‚น27,362
Share price
1.07%
Change (1 day)
41.15%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): โ‚น304.14

According to AbbVie's latest financial reports the company's current EPS (TTM) is โ‚น335.37. In 2022 the company made an earnings per share (EPS) of โ‚น625.35 an increase over its 2021 EPS that were of โ‚น609.30.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น304.14-51.37%
2022โ‚น625.352.63%
2021โ‚น609.30125.21%
2020โ‚น270.55-45.69%
2019โ‚น498.1948.35%
2018โ‚น335.817.6%
2017โ‚น312.09-9.3%
2016โ‚น344.1015.48%
2015โ‚น297.97185.53%
2014โ‚น104.35-57.11%
2013โ‚น243.33-21.69%
2012โ‚น310.7455.73%
2011โ‚น199.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น71.38-78.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,899 764.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,524 354.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น221.67-33.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น291.18-186.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น424.55 26.59%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น627.44 87.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น270.26-19.41%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น662.19 97.45%๐Ÿ‡บ๐Ÿ‡ธ USA